BioSpace News Archive

ROE Dental Laboratory has refocused its significant 3D manufacturing capability and employee expertise to the production of essential medical supplies

Tampa General Hospital is one of the first hospitals in Florida participating in several national research studies seeking effective ways to treat COVID-19

Steinberg Diagnostic Medical Imaging (SDMI) recognizes the increasing need for COVID-19 or symptomatic patients to have diagnostic imaging options outside of the hospital.

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) (the “Company” or “RTSL”), a fully-reporting company with the U.S. Securities and Exchange Commission, is an innovative biotech company specializing in aerosol delivery of legal cannabinoids to the systemic blood stream though the pulmonary route of administration.

Funds help support frontline healthcare workers, vulnerable populations and medical research and development

Rafarma Pharmaceuticals, Inc. is pleased to announce acquisition of all outstanding US and Australian patents from Vladislav Laskavy, PhD.

The annual general meeting in Orexo AB on 16 April 2020 resolved, in accordance with the nomination committee’s proposal, that the number of board members shall be eight with no deputy board members.

HCA Healthcare, one of the nation’s leading healthcare providers, announced it will provide as many as 1,000 ventilators as part of the American Hospital Association’s collaboration with the federal government and health systems to distribute this critical piece of equipment to hospitals experiencing a surge of patients with COVID-19.

As part of the all-of-America approach to fighting the COVID-19 pandemic, the U.S. Food and Drug Administration has been working with partners across the U.S. government, academia and industry to expedite the development and availability of critical medical products to treat this novel virus.

Kaneka Corporation (President: Minoru Tanaka) has reached an agreement with FUJIFILM Corporation (President: Kenji Sukeno) to supply drug substances for anti-influenza drug, Avigan® Tablet (generic name: favipiravir), for the novel coronavirus disease (referred to below as COVID-19).